• 1
    Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA2000; 283:499505.
  • 2
    Li G, Yilmaz M, Kojicic M et al. Outcome of critically ill patients with influenza virus infection. J Clin Virol2009; 46:275278.
  • 3
    MMWR. Estimates of deaths associated with seasonal influenza – United States, 1976–2007. MMWR Morb Mortal Wkly Rep2010; 59:10571062.
  • 4
    Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol1959; 78:11721175.
  • 5
    Harris J. Influenza occurring in pregnant women. JAMA1919; 72:978980.
  • 6
    Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol1998; 148:10941102.
  • 7
    Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis2006; 12:1522.
  • 8
    Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev1996; 18:6476.
  • 9
    Greenberg M, Jacobziner H, Pakter J, Weisl BA. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol1958; 76:897902.
  • 10
    Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA2004; 292:13331340.
  • 11
    Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA2003; 289:179186.
  • 12
    Russell CA, Jones TC, Barr IG et al. The global circulation of seasonal influenza A (H3N2) viruses. Science2008; 320:340346.
  • 13
    Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ2007; 176:463468.
  • 14
    MMWR . 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care – New York City, 2009. MMWR Morb Mortal Wkly Rep2010; 59:321326.
  • 15
    Miller AC, Safi F, Hussain S, Subramanian RA, Elamin EM, Sinert R. Novel influenza A(H1N1) virus among gravid admissions. Arch Intern Med2010; 170:868873.
  • 16
    Siston AM, Rasmussen SA, Honein MA et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA2010; 303:15171525.
  • 17
    Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet2009; 374:451458.
  • 18
    MMWR . Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1) – United States, April 2009–August 2010. MMWR Morb Mortal Wkly Rep2011; 60:11931196.
  • 19
    Ellington SR, Hartman LK, Acosta M et al. Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California. Am J Obstet Gynecol2011; 204:S21S30.
  • 20
    Varner MW, Rice MM, Anderson B et al. Influenza-like illness in hospitalized pregnant and postpartum women during the 2009–2010 H1N1 pandemic. Obstet Gynecol2011; 118:593600.
  • 21
    Hanslik T, Boelle PY, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009–2010. PLoS Curr Influenza2010 Mar 10 [last modified: 2012 Mar 15]. Edition 1.
  • 22
    Karlsson EA, Marcelin G, Webby RJ, Schultz-Cherry S. Review on the impact of pregnancy and obesity on influenza virus infection. Influenza Other Respi Viruses2012; 6:449460.
  • 23
    Mosby LG, Rasmussen SA, Jamieson DJ. 2009 Pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol2011; 205:1018.
  • 24
    MMWR . Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009. MMWR Morb Mortal Wkly Rep2010; 58:14361440.
  • 25
    Lee EH, Wu C, Lee EU et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis2010; 50:14981504.
  • 26
    Louie JK, Acosta M, Winter K et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA2009; 302:18961902.
  • 27
    Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med2009; 361:19351944.
  • 28
    Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill2009; 14.
  • 29
    Michaan N, Amzallag S, Laskov I et al. Maternal and neonatal outcome of pregnant women infected with H1N1 influenza virus (Swine Flu). J Matern Fetal Neonatal Med2012; 25:130132.
  • 30
    Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ2010; 342:d3214.
  • 31
    Yates L, Pierce M, Stephens S et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess2010; 14:109182.
  • 32
    Griffiths PD. Is pregnancy an immunocompromising condition?Rev Med Virol2010; 20:341343.
  • 33
    el-Solh AA, Grant BJ. A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest1996; 110:12991304.
  • 34
    Mighty HE. Acute respiratory failure in pregnancy. Clin Obstet Gynecol2010; 53:360368.
  • 35
    Sciscione AC, Ivester T, Largoza M, Manley J, Shlossman P, Colmorgen GH. Acute pulmonary edema in pregnancy. Obstet Gynecol2003; 101:511515.
  • 36
    Chaouat G. The Th1/Th2 paradigm: still important in pregnancy?Semin Immunopathol2007; 29:95113.
  • 37
    Clark DA, Chaouat G, Wong K, Gorczynski RM, Kinsky R. Tolerance mechanisms in pregnancy: a reappraisal of the role of class I paternal MHC antigens. Am J Reprod Immunol2010; 63:93103.
  • 38
    Elenkov IJ, Wilder RL, Bakalov VK et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab2001; 86:49334938.
  • 39
    Imrie HJ, McGonigle TP, Liu DT, Jones DR. Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy. J Reprod Immunol1996; 31:221227.
  • 40
    Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis2006; 12:16381643.
  • 41
    Ostensen M, Villiger PM. Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol2002; 9:155160.
  • 42
    Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol2007; 29:185191.
  • 43
    Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain1995; 1:253261.
  • 44
    Chaouat G, Tranchot Diallo J, Volumenie JL et al. Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am J Reprod Immunol1997; 37:427434.
  • 45
    Kraus TA, Sperling RS, Engel SM et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol2010; 64:411426.
  • 46
    Guidelines and Recommendations: Prevention Strategies for Seasonal Influenza in Healthcare Settings. 2010. Available at (Accessed 22 March 2012).
  • 47
    Guidelines and Recommendations: Guidance for Prevention and Control of Influenza in the Peri- and Postpartum Settings. 2005. Available at (Accessed 22 March 2012).
  • 48
    Pregnant Women and Novel Influenza A (H1N1) Virus: Considerations for Clinicians. Available at (Accessed 12 August 2010).
  • 49
    Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005–2006 influenza season in the United States. JAMA2006; 295:891894.
  • 50
    MMWR . Update: influenza activity – United States, August 30–October 31, 2009. MMWR Morb Mortal Wkly Rep2009; 58:12361241.
  • 51
    Baz M, Abed Y, Boivin G. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res2007; 74:159162.
  • 52
    Mishin VP, Hayden FG, Gubareva LV. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother2005; 49:45154520.
  • 53
    Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis2010; 50:12521255.
  • 54
    Dharan NJ, Gubareva LV, Meyer JJ et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA2009; 301:10341041.
  • 55
    Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother2005; 55(Suppl. 1):i5i21.
  • 56
    Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ2009; 181:5558.
  • 57
    Donner B, Niranjan V, Hoffmann G. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Drug Saf2010; 33:631642.
  • 58
    Worley KC, Roberts SW, Bawdon RE. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol2008; 2008:927574.
  • 59
    Tomi M, Nishimura T, Nakashima E. Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier. J Pharm Sci2011; 100:37083718.
  • 60
    Svensson T, Granath F, Stephansson O, Kieler H. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Pharmacoepidemiol Drug Saf2011; 20:10301034.
  • 61
    Greer LG, Sheffield JS, Rogers VL, Roberts SW, McIntire DD, Wendel GD Jr. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol2010; 115:711716.
  • 62
    Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA2000; 283:10161024.
  • 63
    Greer LG, Leff RD, Rogers VL et al. Pharmacokinetics of oseltamivir according to trimester of pregnancy. Am J Obstet Gynecol2011; 204:S89S93.
  • 64
    Beigi RH, Han K, Venkataramanan R et al. Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol2011; 204:S84S88.
  • 65
    Wutzler P, Schmidt-Ott R, Hoyer H, Sauerbrei A. Prevalence of influenza A and B antibodies in pregnant women and their offspring. J Clin Virol2009; 46:161164.
  • 66
    Deinard AS, Ogburn P Jr. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am J Obstet Gynecol1981; 140:240245.
  • 67
    Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis1993; 168:647656.
  • 68
    Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis1979; 140:141146.
  • 69
    Jackson LA, Patel SM, Swamy GK et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis2011; 204:854863.
  • 70
    Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep2010; 59:162.
  • 71
    Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis2009; 49:17841792.
  • 72
    Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis1980; 142:844849.
  • 73
    Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J1987; 6:398403.
  • 74
    Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med2008; 359:15551564.
  • 75
    Poehling KA, Szilagyi PG, Staat MA et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol2011; 204:S141S148.
  • 76
    Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD Jr. Cost-effectiveness of universal influenza vaccination in a pregnant population. Obstet Gynecol2006; 107:13231329.
  • 77
    Moro PL, Broder K, Zheteyeva Y et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol2011; 205:473. e19.
  • 78
    ACOG Committee Opinion No. 468: influenza vaccination during pregnancy. Obstet Gynecol2010; 116:10061007.
  • 79
    Yudin MH, Salaripour M, Sgro MD. Pregnant women’s knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J Obstet Gynaecol Can2009; 31:120125.
  • 80
    Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis2008; 8:4452.
  • 81
    MMWR . Influenza vaccination coverage among pregnant women – United States, 2010–11 influenza season. MMWR Morb Mortal Wkly Rep2011; 60:10781082.
  • 82
    MMWR . Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women – 10 states, 2009–10 influenza season. MMWR Morb Mortal Wkly Rep2010; 59:15411545.
  • 83
    MMWR . Influenza vaccination coverage among pregnant women – 29 States and new york city, 2009–10 season. MMWR Morb Mortal Wkly Rep2012; 61:113118.